KELLY O'DONNELL: Open Payments
NPI 1447500319 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 43 payments from 23 companies in 2025. Trend: 2023 $414 · 2024 $1,004 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $161 |
| ABBVIE INC. | 6 | $100 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| PFIZER INC. | 3 | $52 |
| Genentech USA, Inc. | 2 | $41 |
| Incyte Corporation | 2 | $41 |
| Eisai Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Geron Corporation | 2 | $32 |
Products named: WAYRILZ, KEYTRUDA, ELAHERE, OJJAARA, Itovebi, JAKAFI, JEMPERLI, Lenvima.
Industry payments across NJ — which companies pay providers there.
